Doxorubicin Induces Subclinical and Therapeutically Reversible Mitochondrial Injury in Renal Tubular Cells Revealed by Ex Vivo Seahorse Assay and Structured Illumination Microscopy

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
Doxorubicin Induces Subclinical and Therapeutically Reversible Mitochondrial Injury in Renal Tubular Cells Revealed by Ex Vivo Seahorse Assay and Structured Illumination Microscopy

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Koki
Abe
Koki Abe koki.abe@sapmed.ac.jp Sapporo Medical University Department of Pharmacology Sapporo Japan * Sapporo Medical University
Ryo Numazawa numazawa423@sapmed.ac.jp Sapporo Medical University Department of Pharmacology Sapporo Japan -
Tatsuya Sato sato.tatsuya@sapmed.ac.jp Sapporo Medical University Division of Cellular Physiology and Signal Transduction Sapporo Japan -
Yuki Tatekoshi y.tatekoshi@sapmed.ac.jp Sapporo Medical University Department of Pharmacology Sapporo Japan -
Ryusuke Hosoda ryuske@sapmed.ac.jp Sapporo Medical University Department of Pharmacology Sapporo Japan -
Toshifumi Ogawa ogawa@sapmed.ac.jp Sapporo Medical University Division of Cellular Physiology and Signal Transduction Sapporo Japan -
Hidemichi Kouzu kouzu@sapmed.ac.jp Sapporo Medical University Division of Cardiovascular-Kidney-Metabolic Medicine Sapporo Japan -
Toshiyuki Yano tyano@sapmed.ac.jp Sapporo Medical University Division of Cardiovascular-Kidney-Metabolic Medicine Sapporo Japan -
Atsushi Kuno kuno@sapmed.ac.jp Sapporo Medical University Department of Pharmacology Sapporo Japan -